Abstract
Cerebral folate deficiency is characterized by low cerebrospinal fluid (CSF) concentrations of 5-methyltetrahydrofolate and a broad spectrum of clinical signs and symptoms. A patient with progressive spasticity, gait disturbance, speech difficulties, initially diagnosed as a recessive spastic paraplegia recovered on folinic acid (15-30 mg/day) and her 5-methyltetrahydrofolate in CSF normalized. This report demonstrates the importance of CSF investigation in the diagnosis of cerebral folate deficiency and efficiency of folinic acid (5-formyltetrahydrofolate) supplementation.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Brain Diseases / cerebrospinal fluid
-
Brain Diseases / diagnosis*
-
Brain Diseases / drug therapy*
-
Child
-
Child, Preschool
-
Dietary Supplements
-
Dose-Response Relationship, Drug
-
Female
-
Folic Acid Deficiency / cerebrospinal fluid
-
Folic Acid Deficiency / diagnosis*
-
Folic Acid Deficiency / drug therapy*
-
Gait
-
Humans
-
Leucovorin / therapeutic use*
-
Life Style
-
Movement Disorders / drug therapy
-
Paraplegia / diagnosis
-
Paraplegia / etiology
-
Pregnancy
-
Speech Disorders / drug therapy
-
Tetrahydrofolates / cerebrospinal fluid
Substances
-
Tetrahydrofolates
-
Leucovorin
-
5-methyltetrahydrofolate